Diagnostic

Labor and Delivery technology that improves risk prediction 10x for postpartum hemorrhage, saving lives, reducing maternal complications and cutting obstetrics costs for health systems and payers.

We create human-mimicking artificial tumors for high-throughput drug screening, enabling more accurate identification of promising drugs during the preclinical stage.

Moleculera Biosciences is pioneering the diagnosis, treatment, and monitoring of immune-related neuropsychiatric, cardiovascular, Long-COVID, and neurodegenerative disorders. The complexity of immune-mediated chronic conditions has placed an enormous burden on the healthcare system, which is at the core of the future of human health. We enable clinicians with technologies needed to accurately diagnose, treat, and monitor patients suffering from certain chronic debilitating disorders to experience remarkable recoveries.

Parasight System Inc. has developed and manufactures a veterinary diagnostic analyzer that combines antigen-based fluorescence detection with advanced AI-powered image recognition technology, delivering highly accurate and efficient analysis for a variety of diagnostic tests and different medium, including fecal, heartworm, and Lyme disease tests in veterinary practices.